- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| Mi | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| Mo | KeyBanc raises Lifestance Health stock price target on specialty care growth | 1 | Investing.com | ||
| 15.09. | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | - | Investing.com Deutsch | ||
| 11.09. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.09. | LifeStance prices 22.3 million share secondary offering at $12.35 | 1 | Investing.com | ||
| 09.09. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 3 | GlobeNewswire (USA) | ||
| 09.09. | Canaccord raises Lifestance Health stock price target on growth outlook | 1 | Investing.com | ||
| 09.09. | LifeStance stockholders plan to sell 22.3 million shares | 1 | Investing.com | ||
| 10.08. | LifeStance Health gains as Hedgeye adds as new long idea | 1 | Seeking Alpha | ||
| 06.08. | LifeStance Q2 2026 slides: 94% EBITDA surge, raised outlook | 9 | Investing.com | ||
| 06.08. | LifeStance Q2 2026 slides: profitability surges as margins expand | 1 | Investing.com | ||
| 06.08. | LifeStance Health Group beats top-line and bottom-line estimates; raises FY26 outlook | 2 | Seeking Alpha | ||
| 06.08. | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | 791 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 07.07. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | Goldman Sachs initiates Lifestance Health stock at neutral | 1 | Investing.com | ||
| 04.06. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.05. | Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now | 5 | Zacks | ||
| 12.05. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.05. | LifeStance Health Group prices secondary offering at $8.15 per share | 1 | Seeking Alpha | ||
| 08.05. | LifeStance Health prices secondary offering at $8.15 per share | 1 | Investing.com |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,355 | +1,84 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,500 | +2,12 % | EQS-Adhoc: Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen Giza | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Personalentscheidungen / Vorstand
Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,140 | +2,30 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,420 | +4,38 % | 200-Tage-Linie hält: Goldman verpasst Zeiss Meditec einen Dämpfer | Goldman Sachs stuft Carl Zeiss Meditec auf "Sell" ab und senkt das Kursziel auf 23 Euro. Zwischenzeitlich verlor das Papier gut sieben Prozent, fing sich dann aber knapp über der 200-Tage-Linie. Die... ► Artikel lesen | |
| TELADOC HEALTH | 5,176 | +0,39 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| EUROFINS SCIENTIFIC | 76,80 | -0,31 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (Paris:ERF) (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 37,990 | -0,46 % | Boston Scientific Names Fitzgerald Executive Vice President & COO In New Operating Restructure | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX), a medical technology company, on Wednesday announced that it has appointed Joseph M. Fitzgerald as Executive Vice President and Chief Operating... ► Artikel lesen | |
| DEXCOM | 74,80 | -0,53 % | Medtech-Branche: Citi bestätigt Abbott und Dexcom als Top-Picks | ||
| ALIGN TECHNOLOGY | 126,40 | -0,82 % | Stifel cuts Align Technology stock price target on weak demand | ||
| INMODE | 12,620 | -0,43 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| PETMED EXPRESS | 1,134 | -1,22 % | PetMed Express, Inc.: PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director | DELRAY BEACH, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced the appointment of Tamar Elkeles, PhD as a... ► Artikel lesen | |
| TANDEM DIABETES | 14,200 | -1,39 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| INSULET | 121,75 | +0,79 % | Insulet Reports Q2 2026 Results: Full Earnings Call Transcript | ||
| ORGANON | 12,290 | -0,28 % | Biotech Stocks At 52-Week Highs - AbbVie On FDA Designations, HealthStream, Organon & Co. | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 6, 2026, driven by catalysts such as achieving new regulatory milestones.AbbVie Inc. (ABBV)AbbVie is a biopharmaceutical... ► Artikel lesen | |
| MOLINA HEALTHCARE | 177,00 | +0,63 % | Cantor Fitzgerald reiterates Molina Healthcare stock rating at Neutral |
LIFESTANCE HEALTH GROUP INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 12,435 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFESTANCE HEALTH GROUP INC finden Sie auf Wallstreet Online.